Test Price
2,800 AED✅ Home Collection Available
SLC25A3 Gene Mitochondrial Phosphate Carrier Deficiency Genetic Test in UAE | 2,800 AED
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% diagnostic sensitivity via NGS + Sanger confirmation (ISO 9001:2015 certified – certificate INT/EGQ/2509DA/3139).
- Home Phlebotomy Service: VIP Mobile Phlebotomy and temperature‑controlled cold‑chain home collection, available daily from 8 AM to 11 PM.
- Clinical Guidance: Post‑test telephone consultation with a Consultant Medical Genetics specialist.
- Insurance Verification: Direct billing confirmation via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The SLC25A3 NGS test detects pathogenic variants in the SLC25A3 gene associated with mitochondrial phosphate carrier deficiency, a rare cause of hypertrophic cardiomyopathy and muscle weakness. This advanced genetic test enables early diagnosis, family risk assessment, and personalised management. The methodology includes next‑generation sequencing (NGS) followed by Sanger confirmation, ensuring definitive identification of both known and novel variants.
| Feature | SLC25A3 NGS Test | Standard Metabolic Panel |
|---|---|---|
| Precision | 99.9% diagnostic sensitivity | ~85% (biochemical markers only) |
| Methodology | NGS + Sanger confirmation, ISO 9001:2015 | Biochemical phosphate assay |
| Turnaround Time | 3–4 weeks (genetic‑depth analysis) | 2–3 days (does not identify genetic cause) |
Physician Insight & Safety Protocols
“In my practice, I recognise that genetic testing for rare mitochondrial disorders can be emotionally complex. This SLC25A3 analysis delivers precise molecular insight that goes far beyond conventional biochemical markers, enabling targeted management of cardiomyopathy and neuromuscular symptoms. I strongly advise patients to review results with a certified genetic counsellor to fully understand implications for family planning and long‑term care.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403)
⚠️ Important Advisory
Do not discontinue prescribed medication without consulting your doctor. The results of this test may influence treatment but must be integrated with a comprehensive clinical evaluation. Always seek emergency care for sudden chest pain, severe dyspnoea, or syncope.
Safety Exclusion Criteria & Red Flags
- Home Collection Exclusion: Acute febrile illness within 24 hours, inability to provide a blood sample, or age under 18 years without guardian consent. Patients meeting these criteria will be redirected to an accredited clinical facility for sample collection.
- Emergency Red Flags: Sudden chest pain, severe shortness of breath, or loss of consciousness require immediate emergency medical attention; this test is not intended for acute symptom management.
- Legal Framework: Sample collection and genetic data handling comply with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL), Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, and Federal Decree‑Law No. 4 of 2016 on Medical Liability. Only DHA‑licensed healthcare professionals may access and interpret your genetic information.
Patient FAQ & Clinical Guidance
1. Why is this genetic test necessary instead of a standard blood test?
SLC25A3 NGS uniquely identifies pathogenic variants causing mitochondrial phosphate carrier deficiency with 99.9% accuracy, guiding precise cardiac management and family risk assessment. Standard biochemical tests measure phosphate levels but cannot detect the underlying gene defect or predict inheritance patterns. This test, performed using ISO‑certified NGS technology, ensures definitive diagnosis for suspected mitochondrial disorders.
2. How should I prepare for the home blood collection?
No fasting is required; provide your DHA‑validated Emirates ID, signed consent (legal guardian for minors per Federal Decree‑Law No. 4 of 2016), and a brief clinical history form. Our VIP mobile phlebotomist arrives between 8 AM and 11 PM with a cold‑chain certified kit. The sample can be taken as a single drop of blood on an FTA card or a whole‑blood tube. Ensure you have a stable internet connection for post‑test tele‑counselling.
3. Will my insurance cover this test, and how are my results protected?
Most UAE insurers cover this medically necessary genetic test; direct billing verification via WhatsApp +971 54 548 8731 ensures transparent approval before collection. Data privacy is enforced under UAE Federal Decree‑Law No. 45 of 2021 (PDPL) and Federal Law No. 2 of 2019; all genetic data is encrypted and stored on DHA‑licensed servers with access limited to your referring physician and certified genetic counsellors. You retain full rights to request deletion of raw data after reporting.
UAE Regulatory & Data Privacy Adherence
Your genetic data is protected under the highest UAE legal standards. This test operates in full compliance with:
- Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) – ensuring encrypted storage, limited access, and your right to data portability and erasure.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – mandating secure electronic health records and telehealth practices.
- Federal Decree‑Law No. 4 of 2016 on Medical Liability – governing informed consent and clinical safety during sample collection.
The laboratory holds DHA Facility License Number 1143 and adheres to ISO 9001:2015 quality management. All results are reviewed by DHA‑registered healthcare professionals before release.
Clinical & Logistical Metadata
| Test Name | SLC25A3 Gene Mitochondrial Phosphate Carrier Deficiency Genetic Test (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole blood (FTA card or EDTA tube) – VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection |
| Methodology Used | Next‑Generation Sequencing (NGS) with Sanger confirmation; ISO 9001:2015 |
| ICD-10-CM Code | E88.49 (Other disorders of mitochondrial metabolism) |
| LOINC Code | 83306-2 (Gene targeted mutation analysis) |
| DHA Facility License & Laboratory Address | License 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians